首页|超声介入微波消融术辅助治疗原发性小肝癌的临床效果观察

超声介入微波消融术辅助治疗原发性小肝癌的临床效果观察

扫码查看
目的:分析原发性小肝癌患者中,予超声介入微波消融术辅助治疗的价值.方法:将2022年1月~2023年12月厦门市某三甲医院原发性小肝癌患者72例纳入研究,采用数表法分成观察组(36例,超声介入微波消融术+肝动脉化疗栓塞术)、对照组(36例,肝动脉化疗栓塞术),探讨治疗价值.结果:观察组治疗后疗效较对照组高,血清肿瘤标志物较对照组低,肝功能较对照组优,P<0.05.结论:该联合治疗方案,可降低肿瘤标志物水平,改善肝功能,提升疗效.
Observation of the Clinical Effect of Ultrasound Assisted Microwave Ablation in the Treatment of Primary Small Liver Cancer
Objective:To analyze the value of ultrasound intervention and microwave ablation as adjuvant therapy in patients with primary small liver cancer.Methods:72 patients with primary small liver cancer from a tertiary hospital in Xiamen from January 2022 to December 2023 were included in the study.Using a numerical table method,they were divided into an observation group (36 cases,ultrasound interventional microwave ablation+hepatic artery chemoembolization) and a control group (36 cases,hepatic artery chemoembolization) to explore the therapeutic value.Results:The therapeutic effect of the observation group was higher than that of the control group after treatment,with lower serum tumor markers and better liver function than the control group,P<0.05.Conclusion:This combination therapy can reduce tumor marker levels,improve liver function,and enhance efficacy.

primary small liver cancerultrasound intervention microwave ablationhepatic artery chemoembolizationliver functionserum tumor markers

曹蓉

展开 >

厦门大学附属中山医院,福建厦门 361000

原发性小肝癌 超声介入微波消融术 肝动脉化疗栓塞术 肝功能 血清肿瘤标志物

2024

中国医疗器械信息
中国医疗器械行业协会

中国医疗器械信息

影响因子:0.375
ISSN:1006-6586
年,卷(期):2024.30(21)